基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Coronavirus disease 2019 is a serious disease that causes acute respiratory syndrome and negatively affects the central nervous system.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)crosses the blood-brain barrier due to the spike (S) protein on the surface of the viral particles.Thus,it is important to develop compounds that not only have an inhibitory effect but are also capable of completely deactivating the S protein function.This study describes the purposeful modification of porphyrins and proposes compounds,asymmetrically hetaryl-substituted porphyrins with benzothia-zole,benzoxazole,and N-methylbenzimidazole residues,to deactivate the S protein functions.Molecular docking of SARS-CoV-2 proteins with hetaryl-substituted porphyrins showed that the viral S protein,nucleocapsid (N) protein,and non-structural protein 13 (nsp13) exhibited the highest binding affinity.Hetaryl-substituted porphyrins form strong complexes (13-14 kcal/mol) with the receptor-binding domain of the S protein,while the distance from the porphyrins to the receptor-binding motif (RBM)does not exceed 20 (A);therefore,RBM can be oxidized by 1O2,which is generated by porphyrin.Hetaryl-substituted porphyrins interact with the N protein in the serine/arginine-rich region,and a number of vulnerable amino acid residues are located in the photooxidation zone.This damage complicates the packaging of viral RNA into new virions.High-energy binding of hetaryl-substituted porphyrins with the N-and C-terminal domains of nsp13 was observed.This binding blocks the action of nsp13 as an enzyme of exoribonuclease and methyltransferase,thereby preventing RNA replication and processing.A pro-cedure for the synthesis of hetaryl-substituted porphyrins was developed,new compounds were ob-tained,their structures were identified,and their photocatalytic properties were studied.
推荐文章
SARS-CoV-2变异株的遗传学特征和致病特点
SARS病毒
遗传变异
突变
毒力
新型冠状病毒
奥密克戎
合理防治SARS-CoV-2感染的思考
传染病
感染病
COVID-19
预防
治疗
合理
新型冠状病毒SARS-CoV-2感染治疗中的“老药新用”
新型冠状病毒
SARS-CoV-2
抗病毒药物
临床药物
老药新用
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2
来源期刊 药物分析学报(英文版) 学科
关键词
年,卷(期) 2021,(6) 所属期刊栏目 Original Articles
研究方向 页码范围 691-698
页数 8页 分类号
字数 语种 英文
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2021(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
引文网络交叉学科
相关学者/机构
期刊影响力
药物分析学报(英文)
双月刊
2095-1779
61-1484/R
大16开
西安市雁塔西路76号
1985
eng
出版文献量(篇)
639
总下载数(次)
0
总被引数(次)
912
论文1v1指导